Home › Cerebral Palsy › NCT07826494
Short-term Spinal Stimulation Effects in Cerebral Palsy
Acute Effects of Transcutaneous Spinal Stimulation on Spasticity and Gait in Cerebral Palsy
Who can join
Ages 4 to 65 · All sexes
Full eligibility criteria
Inclusion Criteria: Individuals who: * have a diagnosis of spastic cerebral palsy or high likelihood of CP diagnosis * are 4-65 years of age * have spasticity in lower-extremity muscles * are at a functional Gross Motor Function Classification System (GMFCS) Level I-III * can walk for at least 10 minutes with/without support * can understand and follow simple directions * have a stable medical condition, as reported by the caregiver/parent Exclusion Criteria: Individuals who: * who have had lower-extremity surgery or injury in the prior 12 months * have had botulinum toxin injections in the prior 3 months * have had selective dorsal rhizotomy (SDR) in the past * have uncontrolled seizures * have significant cardiovascular or musculoskeletal disease that would prevent full participation * are dependent on ventilation support * have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump) * have established osteoporosis and taking medication for osteoporosis treatment. * have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.) * have active cancer * have received stem cell injections into the spinal cord
About the study
This research study will examine the acute effects of non-invasive spinal stimulation on spasticity and walking in individuals with cerebral palsy. The hypothesis is that walking with spinal stimulation will lead to greater reductions in spasticity than walking without spinal stimulation. Additionally, it is hypothesized that the average step length and Gait Deviation Index will be higher while walking with spinal stimulation compared to walking without spinal stimulation.
What is being tested
- Spinal Stimulation (device)
- Treadmill Walking (other)
Sponsor: University of Washington · Participants: 20 · Started: Aug 13, 2026
Contact the study team
- Katherine Steele, PhD · Phone: 206-685-2390
- Katie Landwehr, MS · Phone: 206-543-0116
Official record on ClinicalTrials.gov — NCT07826494
Locations in the U.S.
| Washington | University of Washington, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.